Structure and function of the B-lymphocyte Epstein-Barr virus/C3d receptor
- PMID: 2136962
- DOI: 10.1016/s0065-230x(08)60814-3
Structure and function of the B-lymphocyte Epstein-Barr virus/C3d receptor
Similar articles
-
Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21).Adv Immunol. 1989;46:183-219. doi: 10.1016/s0065-2776(08)60654-9. Adv Immunol. 1989. PMID: 2551147 Review. No abstract available.
-
Stable expression and function of EBV/C3d receptor following genomic transfection into murine fibroblast L cells.Eur J Immunol. 1990 Feb;20(2):409-16. doi: 10.1002/eji.1830200226. Eur J Immunol. 1990. PMID: 1690137
-
Epstein Barr virus/complement C3d receptor is an interferon alpha receptor.EMBO J. 1991 Apr;10(4):919-26. doi: 10.1002/j.1460-2075.1991.tb08025.x. EMBO J. 1991. PMID: 1849076 Free PMC article.
-
Pneumococcal polysaccharides complexed with C3d bind to human B lymphocytes via complement receptor type 2.Infect Immun. 1991 May;59(5):1839-45. doi: 10.1128/iai.59.5.1839-1845.1991. Infect Immun. 1991. PMID: 1826897 Free PMC article.
-
Cellular receptor for Epstein-Barr virus.Prog Med Virol. 1992;39:116-38. Prog Med Virol. 1992. PMID: 1317595 Review. No abstract available.
Cited by
-
Isolation of avirulent clones of Candida albicans with reduced ability to recognize the CR2 ligand C3d.Infect Immun. 1993 Jun;61(6):2662-9. doi: 10.1128/iai.61.6.2662-2669.1993. Infect Immun. 1993. PMID: 8500905 Free PMC article.
-
Defective expression of CD23 and autocrine growth-stimulation in Epstein-Barr virus (EBV)-transformed B cells from patients with Wiskott-Aldrich syndrome (WAS).Clin Exp Immunol. 1993 Jan;91(1):43-9. doi: 10.1111/j.1365-2249.1993.tb03351.x. Clin Exp Immunol. 1993. PMID: 8380367 Free PMC article.
-
Inhibition of Epstein-Barr virus infection in vitro and in vivo by soluble CR2 (CD21) containing two short consensus repeats.J Virol. 1991 Jul;65(7):3559-65. doi: 10.1128/JVI.65.7.3559-3565.1991. J Virol. 1991. PMID: 1645784 Free PMC article.
-
Mechanisms of enveloped virus entry into animal cells.Adv Drug Deliv Rev. 1998 Oct 5;34(1):65-91. doi: 10.1016/s0169-409x(98)00002-7. Adv Drug Deliv Rev. 1998. PMID: 10837671 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources